CategoriesPaper Científicos septiembre 1, 2017 Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer. Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC Navegación de entradasPrevious post Hyperosmotic stress stimulates autophagy via polycystin-2. Next post Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression